Industrial Policy & Trade Monitor· 2667 actions· ✨ 89 recent

On 2 April 2026 President Trump issued a Presidential Proclamation under Section 232 of the Trade Expansion Act of 1962 ("Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States") imposing a 100% ad valorem tariff on imports of patented pharmaceutical products listed in the FDA Orange Book and Purple Book, together with the active pharmaceutical ingredients (APIs) and key starting materials used to make them. The base rate takes effect at 12:01 a.m. EDT on 31 July 2026 for the 17 manufacturers identified in Annex III, and on 29 September 2026 for all other companies. The proclamation adopts findings of the Section 232 investigation initiated by the Department of Commerce on 14 April 2025 into pharmaceuticals and APIs as a national- security supply-chain risk. The instrument is structured around a multi-tier rate ladder rather than a flat tariff: concessionary 15% rates for EU/Japan/South Korea/Switzerland/Liechtenstein under reciprocal-deal tracks, 10% for the UK with a pathway to 0% under the pending UK pharmaceutical agreement, a "+20%" surcharge for companies operating under a Commerce-approved onshoring plan (until 2 April 2030), and a 0% pathway for companies that combine an approved onshoring plan with an MFN-pricing agreement with HHS (until 20 January 2029). Generics, biosimilars and their ingredients, orphan drugs, nuclear medicines, plasma-derived therapies, fertility treatments, and cell/gene therapies are carved out.

Premier Li Qiang signed State Council Order No. 834 on 31 March 2026 promulgating the "Provisions on Industrial Chain and Supply Chain Security" (18 articles), adopted at the State Council executive meeting on 13 March 2026 and effective on the date of publication. The Provisions are the first dedicated PRC administrative regulation on industrial- and supply-chain security and consolidate authorities drawn from the National Security Law, Foreign Relations Law, Anti-Foreign Sanctions Law, and Foreign Trade Law into a horizontal defensive framework. They establish a cross-agency coordination mechanism spanning roughly 15 central departments (industrial, security, cyberspace, customs and financial regulators) plus provincial governments; create a security-investigation system; and vest broad countermeasure authority over both foreign states (Article 14 — import/export prohibitions and special levies) and foreign organisations and individuals (Article 15 — import/export bans, China-investment bars, transaction prohibitions, entry bars and revocation of work or residence permits, with extension to effectively-controlled subsidiaries). The Provisions also impose compliance, information-sharing, strategic-reserve and emergency-response obligations on PRC organisations and individuals, and authorise requisition, mandated production and directed transportation in the event of supply-chain disruption.

On 5 March 2025 the European Commission adopted Communication COM(2025) 95 final, the "Industrial Action Plan for the European Automotive Sector", a horizontal sectoral industrial-policy framework structured around five pillars: innovation and digitalisation, clean mobility, competitiveness and supply-chain resilience, skills and the social dimension, and a global level playing field. Headline financial commitments include EUR 1bn under Horizon Europe for SDV/AI in mobility (2025-2027), EUR 1.8bn Innovation Fund earmark for EU battery cell manufacturing, EUR 350m for next-generation battery R&D (2025-2027), and EUR 570m under the Alternative Fuels Infrastructure Facility (2025-2026) for heavy-duty charging corridors. The plan also delivers a targeted CO2-standards flexibility allowing 2025-2027 combined-year compliance for cars and vans, and the launch of the European Connected and Autonomous Vehicle Alliance.

The CHIPS and Science Act (Public Law 117-167), signed into law by President Biden on 9 August 2022, appropriated $52.7 billion in direct semiconductor industry support: $39B in manufacturing incentives administered by the Commerce Department, $13.2B for R&D and workforce, and $0.5B for legacy-chip and supply-chain programs. It also created an Advanced Manufacturing Investment Credit (Section 48D) — a 25% refundable investment tax credit on qualified semiconductor manufacturing property. The law included a "guardrails" clause prohibiting recipients from expanding advanced-node capacity in countries of concern (most prominently China) for 10 years following award.

The Law of the People's Republic of China on Countering Foreign Sanctions was adopted at the 29th meeting of the Standing Committee of the 13th NPC on 10 June 2021 (Presidential Order No. 90, President Xi Jinping) and entered into force on the same day. Comprising 16 articles, it establishes the unified statutory framework for China's countermeasure regime against foreign states or organisations that "violate international law and basic norms of international relations" by imposing discriminatory restrictive measures against Chinese citizens and organisations — the parent authority under which every China countermeasure-list, Unreliable Entity List, blocking-statute, and supply-chain-security instrument in the IPTM register operates. Article 6 enumerates the countermeasure toolbox (visa denial, asset freezes, transaction prohibitions, and "other necessary measures"); Article 12 is the blocking-statute provision that prohibits PRC persons from implementing foreign discriminatory measures — first operationalised in May 2026 against five US-sanctions-compliant refineries.